FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emanuela Messa

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Ludovica Riera; Francesca Sismondi; Daniela Toppino; Umberto Vitolo; Ernesta Audisio; Stefano D'Ardia; Cristiana Di Bello; Paola Francia Di Celle; Chiara Frairia; Giorgio Inghirami; Filippo Marmont; Emanuela Messa; Achille Pich
Core binding factor acute myeloid leukaemia and c-KIT mutations.
Sara Galimberti; Daniela Gioia; Francesca Guerrini; Emanuela Messa; Giuseppe A Palumbo; Iacopo Petrini; Mario Petrini; Flavia Salvi; Daniela Cilloni; Alessandro Levis
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emanuela Messa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ludovica Riera; Francesca Sismondi; Daniela Toppino; Umberto Vitolo; Ernesta Audisio; Stefano D'Ardia; Cristiana Di Bello; Paola Francia Di Celle; Chiara Frairia; Giorgio Inghirami; Filippo Marmont; Emanuela Messa; Achille Pich
Core binding factor acute myeloid leukaemia and c-KIT mutations.
Oncology reports 2013;29(5):1867-72.
2012: Sara Galimberti; Daniela Gioia; Francesca Guerrini; Emanuela Messa; Giuseppe A Palumbo; Iacopo Petrini; Mario Petrini; Flavia Salvi; Daniela Cilloni; Alessandro Levis
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
Journal of hematology & oncology 2012;5():53.
2010: Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.
Haematologica 2010;95(8):1308-16.
2010: Daniela Cilloni; Emanuela Messa; Antonia Rotolo; Giuseppe Saglio
Emerging drugs for chronic myeloid leukemia.
Expert opinion on emerging drugs 2010;15(2):175-84.
2010: Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
Iron chelation therapy in myelodysplastic syndromes.
Advances in hematology 2010;2010():756289.
2009: Emanuela Messa; R M Pellegrino; A Palmieri; Sonia Carturan; Daniela Cilloni; Giuseppe Saglio; Antonella Roetto
Identification of a novel mutation in the L ferritin iron-responsive element causing hereditary hyperferritinemia-cataract syndrome.
Acta haematologica 2009;122(4):223-5.
2008: Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Enrico Gottardi; Milena Fava; Sonia Carturan; Renata Catalano; Enrico Bracco; Emanuela Messa; Paolo Nicoli; Daniela Diverio; Miguel A Sanz; giovanni martinelli; Francesco Lo Coco; Giuseppe Saglio
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Haematologica 2008;93(6):921-4.
2008: Daniela Cilloni; Francesca Messa; Valentina Rosso; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Renata Catalano; Marisa Pautasso; C Panuzzo; P Nicoli; Emanuela Messa; Alessandro Morotti; I Iacobucci; giovanni martinelli; Enrico Bracco; Giuseppe Saglio
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Leukemia 2008;22(6):1234-40.
2008: Emanuela Messa; Daniela Cilloni; Francesca Messa; Francesca Arruga; A Roetto; Giuseppe Saglio
Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis.
Acta haematologica 2008;120(2):70-4.
2008: Paolo Nicoli; Ilaria Defilippi; Sonia Carturan; Antonella Roetto; Francesca Messa; Francesca Arruga; Emanuela Messa; Antonia Rotolo; Ilaria Iacobucci; Enrico Bracco; Giuseppe Saglio; Daniela Cilloni
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies.
Acta haematologica 2008;120(1):47-50.
2007: Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Mario Arpinati; Stefania Paolini; Anna Candoni; Renato Fanin; Emanuela Messa; Maria Teresa Pirrotta; Francesco Lauria; Giuseppe Visani; Daniele Alberti; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.
Haematologica 2007;92(12):1721-2.
2007: Daniela Cilloni; Francesca Messa; giovanni martinelli; Enrico Gottardi; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Milena Fava; Emilia Giugliano; Valentina Rosso; Renata Catalano; Serena Merante; P Nicoli; Michela Rondoni; Emanuela Ottaviani; Simona Soverini; Mario Tiribelli; Fabrizio Pane; Michele Baccarani; Giuseppe Saglio
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
Leukemia 2007;21(7):1442-50.
2007: Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
A young man with persistent eosinophilia.
Internal and emergency medicine 2007;2(2):107-12.
2006: Daniela Cilloni; Emanuela Messa; Francesca Messa; Sonia Carturan; Ilaria Defilippi; Francesca Arruga; Valentina Rosso; Renata Catalano; Enrico Bracco; Paolo Nicoli; Giuseppe Saglio
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Annals of the New York Academy of Sciences 2006;1089():411-23.
2006: Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Alessandro Morotti; Emanuela Messa; Sonia Carturan; Emilia Giugliano; Marisa Pautasso; Enrico Bracco; Valentina Rosso; A Sen; giovanni martinelli; Michele Baccarani; Giuseppe Saglio
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance.
Leukemia 2006;20(1):61-7.
2005: Chiara Pilatrino; Daniela Cilloni; Emanuela Messa; Alessandro Morotti; Emilia Giugliano; Marisa Pautasso; Ubaldo Familiari; Susanna Cappia; Pier Giuseppe Pelicci; Francesco Lo Coco; Giuseppe Saglio; Angelo Guerrasio
Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Cancer 2005;104(1):101-9.
2004: Michele Baccarani; giovanni martinelli; Gianantonio Rosti; Elena Trabacchi; Nicoletta Testoni; Simona Bassi; Marilina Amabile; Simona Soverini; Fausto Castagnetti; Daniela Cilloni; Barbara Izzo; Antonio de Vivo; Emanuela Messa; Francesca Bonifazi; Angela Poerio; Simona Luatti; Emilia Giugliano; Daniele Alberti; Gianluca Fincato; Domenico Russo; Fabrizio Pane; Giuseppe Saglio
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.
Blood 2004;104(13):4245-51.
2004: Giuseppe Saglio; Alessandro Morotti; Giovanna Mattioli; Emanuela Messa; Emilia Giugliano; Gisella Volpe; Giovanna Rege-Cambrin; Daniela Cilloni
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.
Annals of the New York Academy of Sciences 2004;1028():423-31.
2004: Daniela Cilloni; Francesca Messa; Sonia Carturan; Francesca Arruga; Ilaria Defilippi; Emanuela Messa; Enrico Gottardi; Giuseppe Saglio
Myelodysplastic syndromes.
Annals of the New York Academy of Sciences 2004;1028():400-8.
2004: Daniela Cilloni; Francesca Messa; Enrico Gottardi; Milena Fava; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Alessandro Morotti; Emilia Giugliano; Giovanna Rege-Cambrin; Daniele Alberti; Michele Baccarani; Giuseppe Saglio
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Cancer 2004;101(5):979-88.
2003: Daniela Cilloni; Sonia Carturan; Enrico Gottardi; Francesca Messa; Emanuela Messa; Milena Fava; Daniela Diverio; Angelo Guerrasio; Francesco Lo Coco; Giuseppe Saglio
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.
Blood 2003;102(7):2705-6.